{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:40:43Z","timestamp":1759333243798},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Council of Scientific and Industrial Research (CSIR), New Delhi, India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.peptides.2011.09.014","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T13:45:26Z","timestamp":1316526326000},"page":"2131-2133","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Pam3Cys induced protection on the therapeutic efficacy of miltefosine against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"32","author":[{"given":"Nishi","family":"Shakya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraddha A.","family":"Sane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shagun","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2011.09.014_bib0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nrd3012","article-title":"Carbohydrate vaccines: developing sweet solutions to sticky situations?","volume":"9","author":"Astronomo","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.peptides.2011.09.014_bib0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1462-5822.2008.01146.x","article-title":"Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example","volume":"10","author":"Bogdan","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.peptides.2011.09.014_bib0015","doi-asserted-by":"crossref","first-page":"113R","DOI":"10.1093\/glycob\/cwj125","article-title":"Glycopeptides as versatile tools for glycobiology","volume":"16","author":"Buskas","year":"2006","journal-title":"Glycobiology"},{"issue":"36","key":"10.1016\/j.peptides.2011.09.014_bib0020","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1039\/b908664c","article-title":"Immunotherapy for cancer: synthetic carbohydrate-based vaccines","volume":"28","author":"Buskas","year":"2009","journal-title":"Chem Commun"},{"key":"10.1016\/j.peptides.2011.09.014_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis, what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.peptides.2011.09.014_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"den Boer","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"issue":"5\u20136","key":"10.1016\/j.peptides.2011.09.014_bib0035","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.cbpa.2009.08.010","article-title":"Recent development in carbohydrate-based cancer vaccines","volume":"13","author":"Guo","year":"2009","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.peptides.2011.09.014_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.actatropica.2004.11.009","article-title":"Efficacy of picroliv combination with miltefosine, an orally effective antileishmanial drug against experimental visceral leishmaniasis","volume":"94","author":"Gupta","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.peptides.2011.09.014_bib0045","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","article-title":"CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis","volume":"65","author":"Sane","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.peptides.2011.09.014_bib0050","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.peptides.2004.06.011","article-title":"Efficacy of human \u03b2-casein fragment (54\u201359) and its synthetic analogue compound 89\/215 against Leishmania donovani in hamsters","volume":"25","author":"Sharma","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2011.09.014_bib0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.170.1.194","article-title":"Toll-like receptor 2 ligands as adjuvants for human Th1 responses","volume":"170","author":"Sieling","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2011.09.014_bib0060","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1128\/AAC.46.3.929-931.2002","article-title":"In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii","volume":"46","author":"Yardley","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.peptides.2011.09.014_bib0065","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.169.9.4905","article-title":"Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines","volume":"169","author":"Zeng","year":"2002","journal-title":"J Immunol"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978111003809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978111003809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:52:47Z","timestamp":1543539167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978111003809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0196978111003809"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2011.09.014","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}